4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer.

[1]  David L Rimm,et al.  Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. , 2002, Cancer research.

[2]  K. Yamashita,et al.  Abnormal nucleotide repeat sequence in the TGF‐βRII gene in hepatocellular carcinoma and in uninvolved liver tissue , 2001, The Journal of pathology.

[3]  T. Wheeler,et al.  Predictive value of expression of transforming growth factor‐β1 and its receptors in transitional cell carcinoma of the urinary bladder , 2001, Cancer.

[4]  Y. Hattori,et al.  Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. , 2001, Life sciences.

[5]  A. Roberts,et al.  Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner , 2001, Oncogene.

[6]  Ester Piek,et al.  Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .

[7]  Y. Soh,et al.  Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. , 2000, Molecular pharmacology.

[8]  G. Poli.  Pathogenesis of liver fibrosis: role of oxidative stress. , 2000, Molecular aspects of medicine.

[9]  C. Napoli,et al.  Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells , 2000 .

[10]  K. Matsuzaki,et al.  Down-regulation of TGF-β receptors in human colorectal cancer: implications for cancer development , 1999, British Journal of Cancer.

[11]  Yoshimasa Nakamura,et al.  Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation , 1999, The Journal of Biological Chemistry.

[12]  G. Bellomo,et al.  HNE interacts directly with JNK isoforms in human hepatic stellate cells. , 1998, The Journal of clinical investigation.

[13]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[14]  G. Poli,et al.  The lipid peroxidation end product 4‐hydroxy‐2,3‐nonenal up‐regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Dianzani,et al.  Lipid peroxidation and cancer. , 1993, Critical reviews in oncology/hematology.

[16]  Keunchil Park,et al.  Reduced transforming growth factor-β type II receptor (TGF-β RII) expression in adenocarcinoma of the lung , 1999 .

[17]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[18]  G. Poli,et al.  Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. , 1997, Free radical biology & medicine.

[19]  G. Poli,et al.  Oxidative damage and fibrogenesis. , 1997, Free radical biology & medicine.

[20]  K. Cheeseman.  Mechanisms and effects of lipid peroxidation. , 1993, Molecular aspects of medicine.

[21]  D. Eccles,et al.  Transforming Growth Factor (cid:1) Receptor 1 Polyalanine Polymorphism and Exon 5 Mutation Analysis in Breast and Ovarian Cancer , 2022 .